.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Fuji
Queensland Health
Deloitte
Johnson and Johnson
US Army
Fish and Richardson
Daiichi Sankyo
QuintilesIMS
McKinsey

Generated: November 19, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: miltefosine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Knight Theraps
IMPAVIDO
miltefosine
CAPSULE;ORAL204684NDAPaladin Therapeutics Inc.61744-050-012 BLISTER PACK in 1 CARTON (61744-050-01) > 14 CAPSULE in 1 BLISTER PACK
Knight Theraps
IMPAVIDO
miltefosine
CAPSULE;ORAL204684NDAProfounda, Inc.69051-300-012 BLISTER PACK in 1 CARTON (69051-300-01) > 14 CAPSULE in 1 BLISTER PACK
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Covington
Express Scripts
US Department of Justice
Baxter
Federal Trade Commission
Deloitte
Boehringer Ingelheim
McKinsey

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot